Comparison of Various Hematopoietic Stem Cell Mobilization Regimens in Patients with Lymphoma and Myeloma

YILMAZ U., SALİM O., YÜCEL O. K., Iltar U., ÜNDAR L.

CLINICAL LABORATORY, cilt.65, sa.10, ss.1845-1852, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 65 Sayı: 10
  • Basım Tarihi: 2019
  • Doi Numarası: 10.7754/clin.lab.2019.190214
  • Dergi Adı: CLINICAL LABORATORY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1845-1852
  • Anahtar Kelimeler: lymphoma, myeloma, stem cell mobilization, IEV regimen, COLONY-STIMULATING FACTOR, HIGH-DOSE CYCLOPHOSPHAMIDE, BLOOD PROGENITOR-CELL, G-CSF, MULTIPLE-MYELOMA, MOBILIZING REGIMEN, SALVAGE THERAPY, ETOPOSIDE, IFOSFAMIDE, TRANSPLANTATION
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background: The aim of this study was to evaluate the efficacy of cyclophosphamide-based (CB) and platinum-based (PB) chemotherapy regimens for hematopoietic stem cell mobilization in patients with Multiple Myeloma (MM), Hodgkin's lymphoma (HL), and non-Hodgkin's lymphoma (NHL) and the less well-known IEV (iphosphamide, epirubicin, etoposide) regimen in terms of stem cell harvesting competence, factors affecting stem cell competence, and toxicity.